OPTN 0.93 (-8.82%)
US68404V1008Drug ManufacturersDrug Manufacturers - Specialty & Generic

OptiNose (OPTN) Competitor Comparison

We are evaluating the key criteria listed to compare OptiNose (OPTN) against its competitors in the Drug Manufacturers - Specialty & Generic industry.

Performance 3 years - OPTN ranking 31 / 55

These are the competitors of OptiNose in the industry Drug Manufacturers - Specialty & Generic ranked by performance 3 years
1. Amphastar Pharmaceuticals AMPH
122.21
2. ANI Pharmaceuticals ANIP
107.38
3. Harrow Health HROW
80.46
4. Avadel Pharmaceuticals AVDL
79.87
5. Collegium Pharmaceutical COLL
53.79
6. Vifor Pharma G2AB.F
39.09
7. Alvotech ALVO
28.84
8. ProPhase Labs PRPH
23.02
9. Teva Pharmaceutical Industries TEVA
21.13
10. Kolinpharma KIP.MI
17.3
11. Supernus Pharmaceuticals SUPN
6.74
12. Zoetis ZTS
-6.3
13. Amneal Pharmaceuticals AMRX
-7.07
14. Evolus EOLS
-12.2
15. Kamada KMDA
-16.15
16. Ironwood Pharmaceuticals IRWD
-22.29
17. Perrigo PRGO
-25.04
18. Taro Pharmaceutical Industries TARO
-42.52
19. Phibro Animal Health PAHC
-46.4
20. Cumberland Pharmaceuticals CPIX
-47.25
21. Green Thumb Industries R9U2.F
-47.9
22. Catalent CTLT
-48.11
23. Journey Medical DERM
-49.2
24. Elanco Animal Health ELAN
-51.36
25. PetIQ PETQ
-54.88
26. Linc LNC
-55.24
27. Pacira BioSciences PCRX
-60.38
28. Clever Leaves Holdings CLVR
-62.25
29. Alimera Sciences ALIM
-62.91
30. Zynerba Pharmaceuticals ZYNE
-64.48
31. OptiNose OPTN
-65.44
32. Societal CDMO SCTL
-65.73
33. Curaleaf Holdings CURLF
-66.92
34. Regencell Bioscience Holdings RGC
-68.25
35. Cronos Group CRON
-71.12
36. Bausch Health Companies BHC
-71.34
37. Procaps Group PROC
-73.23
38. Embecta EMBC
-78.65
39. Jupiter Wellness JUPW
-80
40. SCYNEXIS SCYX
-82.74
41. Solid Biosciences SLDB
-86.78
42. Relmada Therapeutics RLMD
-86.85
43. Ascend Wellness Holdings AAWH
-87.24
44. Organogenesis Holdings ORGO
-87.64
45. Alpha Teknova TKNO
-88.37
46. Eagle Pharmaceuticals EGRX
-88.93
47. Ayr Wellness 3KJB.F
-89.87
48. Tilray Brands TLRY
-89.89
49. Theratechnologies THTX
-90.85
50. Universe Pharmaceuticals UPC
-93.7
51. Neoleukin Therapeutics NLTX
-94.43
52. Emergent BioSolutions EBS
-97.34
53. Biofrontera BFRI
-97.44
54. Flora Growth FLGC
-98.2
55. MedAvail Holdings MDVL
-100

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.